You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Inactivating mutations

Showing 1 - 25 of 2,504
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TSC1, TSC2, Tuberous Sclerosis Complex Trial in Boston, New York (Everolimus)

Completed
Has Results
  • TSC1
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 14, 2020

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)

Recruiting
  • Lymphangioleiomyomatosis
  • Tuberous Sclerosis Complex
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 20, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

COVID-19 by SARS-CoV-2 Infection Trial in Cannes, Nice (COVID-19 patients)

Recruiting
  • COVID-19 by SARS-CoV-2 Infection
  • COVID-19 patients
  • Cannes, Alpes Maritimes, France
  • +1 more
Sep 13, 2021

Lymphedema Trial (Micro-biopsies)

Not yet recruiting
  • Lymphedema
  • Micro-biopsies
  • (no location specified)
Jan 2, 2023

Idiopathic Infantile Hypercalcemia - Mild Form Trial in Toronto (Rifampin 150 mg, 300 mg capsules and 25 mg/mL oral suspension)

Recruiting
  • Idiopathic Infantile Hypercalcemia - Mild Form
  • Rifampin 150 mg, 300 mg capsules and 25 mg/mL oral suspension
  • Toronto, Ontario, Canada
    The Hospital for Sick Children
Aug 30, 2021

Lymphoma, Relapsed and Refractory, DLBCL and Follicular Lymphoma Trial in New York (Mocetinostat)

Active, not recruiting
  • Lymphoma
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 17, 2021

Severe Combined Immunodeficiency Trial in San Francisco (AProArt, CliniMACS® CD34 Reagent System cell sorter device, Busulfan)

Recruiting
  • Severe Combined Immunodeficiency
  • San Francisco, California
    University of California, San Francisco (UCSF) Children's Hospit
Feb 4, 2022

hepatoceLlular Carcinoma in Post-transplant HCC Recurrence

Recruiting
  • Hepatocellular Carcinoma Recurrent
  • Liver Transplant; Complications
  • liver transplant
  • +2 more
  • Shanghai, China
    Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Jun 21, 2021

Lymphangioleiomyomatosis Trial in Beijing (11C-Choline)

Not yet recruiting
  • Lymphangioleiomyomatosis
  • Beijing, Dongcheng, China
    Peking union medical college hospital
Oct 8, 2021

Liquid Biopsy Genomic Profiling on Treatment Metastatic Prostate

Recruiting
  • Metastatic Prostate Cancer
  • Liquid Biopsy
  • Archival Tumor DNA sequencing
  • Barcelona, Spain
    SOLTI Cancer Research Group
May 22, 2023

Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

Not yet recruiting
  • Adrenal Cortical Carcinoma
  • +3 more
  • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

Not yet recruiting
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 23, 2022

Metastatic Prostate Cancer Trial in United States (High dose testosterone)

Recruiting
  • Metastatic Prostate Cancer
  • High dose testosterone
  • Aurora, Colorado
  • +9 more
Sep 15, 2021

Gastric Cancer, Gastric Tumors, Gastric Adenocarcinoma Trial run by the National Cancer Institute (NCI) (Cellvizio (Registered

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • Cellvizio (Registered trademark)Real-Time In Vivo Cellular Imaging Platform with Confocal Miniprobes
  • Olympus GIF 190 endoscope
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +125 more
Nov 21, 2022

Adults Treated With Asfotase Alfa for Hypophosphatasia

Completed
  • Hypophosphatasia
    • Würzburg, Germany
      Clinical Trial Unit, Orthopedic Department, Wuerzburg University
    Jul 11, 2022

    X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

    Suspended
    • X-linked Severe Combined Immunodeficiency (XSCID)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Neuroendocrine Carcinoma Trial in France (FOLFOXIRI Protocol, Cisplatin injection)

    Recruiting
    • Neuroendocrine Carcinoma
    • FOLFOXIRI Protocol
    • Cisplatin injection
    • Caen, France
    • +5 more
    Apr 13, 2021

    Pituitary Tumours: Prevalence of Associated Neoplasia

    Recruiting
    • Pituitary Tumor
    • +4 more
    • Registration of familial forms and associated neoplasia
    • Pozzilli, IS, Italy
      Neuromed
    Aug 31, 2021

    NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • MK-2870
    • +2 more
    • (no location specified)
    Oct 3, 2023

    Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)

    Completed
    • Metastatic Colorectal Cancer
    • Milan, MI, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Apr 1, 2022

    SMN Circular RNAs as Potential New Targets and Biomarkers for

    Recruiting
    • Spinal Muscular Atrophy
      • Rome, Italy
        Policlinico gemelli
      Feb 27, 2023

      Pediatric Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

      Not yet recruiting
      • Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF)
      • +2 more
        • (no location specified)
        Aug 25, 2023